13D/13G Filings - Aspire Capital Fund LLC

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2021-02-17
06:10 am
Purchase
2021-02-12 13G aTyr Pharma, Inc.
LIFE
Aspire Capital Fund LLC 1,312,537
9.150%
1,312,537increase
(New Position)
Filing
History
2020-12-23
4:42 pm
Purchase
2020-12-23 13G Cyclacel Pharmaceuticals, Inc.
CYCC
Aspire Capital Fund LLC 18,000
5.050%
18,000increase
(New Position)
Filing
History
2020-07-02
06:21 am
Purchase
2020-07-01 13G Akari Therapeutics, Plc
AKTX
Aspire Capital Fund LLC 33,679,045
19.890%
33,679,045increase
(New Position)
Filing
History
2020-07-02
06:19 am
Purchase
2020-06-30 13G Mereo BioPharma Group plc
MREO
Aspire Capital Fund LLC 20,680,882
6.110%
20,680,882increase
(New Position)
Filing
History